GPT and cancer: We currently do not know the exact reason why a specific requirement of ADAR1p110 for suppression of telomeric R-loops is restricted to non-ALT cells (Fig. 9a, b and Supplementary Fig. 10), as widespread presence of telomeric variant repeats has been detected in both ALT and non-ALT cancer cells (Fig. 5).